These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1893436)

  • 1. [The effect of enalapril on the development of diabetic nephropathy in children and adolescents].
    Lebl J; Kolousková S; Snajderová M
    Cesk Pediatr; 1991 Mar; 46(3):149-52. PubMed ID: 1893436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term enalapril treatment in diabetic nephropathy.
    Mulec H; Johnsen SA; Björck S
    Kidney Int Suppl; 1994 Feb; 45():S141-4. PubMed ID: 8158883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.
    de Mello VD; Zelmanovitz T; Azevedo MJ; de Paula TP; Gross JL
    J Ren Nutr; 2008 Sep; 18(5):440-7. PubMed ID: 18721739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
    Moriyama T; Oka K; Ueda H; Imai E
    Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
    BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical problems in the management of hypertension in the diabetic patient.
    O'Hare JP
    J Diabetes Complications; 1996; 10(3):146-8. PubMed ID: 8807462
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropathy].
    Barkai L; Soós A; Vámosi I
    Orv Hetil; 1996 Nov; 137(46):2565-8. PubMed ID: 9005384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
    Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
    Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II.
    Ravid M; Savin H; Jutrin I; Bental T; Lang R; Lishner M
    Kidney Int Suppl; 1994 Feb; 45():S161-4. PubMed ID: 8158887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The recovery of the kidney filtration functional reserve in diabetes mellitus patients on captopril treatment].
    Shestakova MV; Mukhin NA; Dedov II; Titov VN; Pomerantseva NV; Okunev DIu; Lipitskaia IIa
    Ter Arkh; 1991; 63(6):50-5. PubMed ID: 1948747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR; Jackson B
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE-I and ARBs in early diabetic nephropathy.
    Mauer M; Zinman B; Gardiner R; Drummond KN; Suissa S; Donnelly SM; Strand TD; Kramer MS; Klein R; Sinaiko AR
    J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):262-9. PubMed ID: 12584670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
    Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
    Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.
    Dunn BR; Zatz R; Rennke HG; Meyer TW; Anderson S; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S251-4. PubMed ID: 3033178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children.
    Drummond K; Levy-Marchal C; Laborde K; Kindermans C; Wright C; Dechaux M; Czernichow P
    Diabetologia; 1989 Apr; 32(4):255-60. PubMed ID: 2547680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.